|Articles|November 1, 2002

Applied Clinical Trials Supplements

Supplements-08-02-2002
Volume 0
Issue 0

Update 2002 IT Solutions Directory

Our 10th annual guide to applications highlights software, Web-based solutions, and more.

External Link - article-37090.pdf

Articles in this issue

about 24 years ago

Article

Scaling up EDC: How to Move Away from Paper Trials

about 24 years ago

Article

Supporting EDC in a Clinical Trial Environment

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

© ABCDstock - © ABCDstock - stock.adobe.com

Beyond Patient Centricity: What Rare Disease Research Gets Right

BySylvain Berthelot

September 4th 2026

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

ByAbigail Dirks, MS,Sylviane de Viron,Andy Studna, Senior Editor

September 4th 2026

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files

ByAndy Studna, Senior Editor

September 4th 2026

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

ByAndy Studna, Senior Editor

September 3rd 2026

Why Time Savings Is the Largest Driver of RBQM's Financial Value

ByAbigail Dirks, MS,Sylviane de Viron,Andy Studna, Senior Editor

September 3rd 2026

Update 2002 IT Solutions Directory

Articles in this issue

Related Content

Beyond Patient Centricity: What Rare Disease Research Gets Right

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

Why Time Savings Is the Largest Driver of RBQM's Financial Value

Trending on Applied Clinical Trials Online

Beyond Patient Centricity: What Rare Disease Research Gets Right

AI Moves Patient Recruitment from Trial Bottleneck to Competitive Edge: A 2026 Perspective

Fortrea to Acquire Worldwide Clinical Trials' Early Phase Services Division in $45 Million Deal

FDA Reaffirms GCP Standards Amid Growing Concerns Over Foreign Clinical Trial Data

From Perspective to Action: Addressing the Real Cost Pressures in Clinical Trial Budgeting